Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the<scp>COVID</scp>‐19 pandemic

Telogen effluvium (TE) is characterized by diffuse hair shedding 2‐3 months after a stressor, and COVID‐19 infection is potentially one such stressor. Those who were infected with the virus were under immense psychosocial and physiologic stress. We retrospectively reviewed electronic medical records of 552 patients who were evaluated by a Henry Ford Health System dermatologist between February 2020 and September 2020 and had a diagnosis of COVID‐19 infection. Ten patients were identified with TE attributed to COVID‐19 infection and described their presentations as a case series. For the ten patients selected, the mean age was 48.5 years old and 90% were female. Six of the patients were Black, one Middle Eastern, and three White. On average, the hair shedding began 50 days after the first symptom of COVID‐19 infection. About 80% of these patients were treated with antibiotics, systemic corticosteroids, and/or hydroxychloroquine for their COVID‐19 infection and 70% were hospitalized. The presentations of these patients suggest that COVID‐19 infection may be a significant trigger of TE. TE caused by hydroxychloroquine, azithromycin or other medications cannot be ruled out, and the global pandemic itself is a source of psychosocial stress. Further studies will be needed to understand the long‐term prevalence and prognosis of TE associated with COVID‐19 infection.

Section: Discussionmentioning

confidence: 93%

Telogen effluvium associated with COVID‐19 infection

Olds

Liu

Luk

et al. 2021

“…The same results were obtained when patients were further subcategorized into two rosacea phenotypes, PP and EE. PP patients showed a higher median age (49 [45-54] years) than EE patients (44 [37-51] years; P = .039) while no difference was observed in the average time wearing a mask/day (8 [7.5-9] vs 8 [7][8][9] h/day, respectively; P = .94).…”

Section: Mask Rosacea or Rosacea Due To Masksmentioning

confidence: 99%

COVID‐19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi‐center, real‐life, telemedical, and observational prospective study

Damiani

Gironi

Grada

et al. 2021

Masks are essential for COVID-19 prevention, but recently they were suggested to modify cutaneous facial microenvironment and trigger facial dermatoses. To evaluate mask-related rosacea and acne (maskne) in untreated patients during lockdown. In this multi-center, real-life, observational prospective study, we enrolled stable, untreated acne and rosacea patients that wore masks during lockdown at least 6 h/ day. They underwent two teledermatological consultations, at the baseline and after 6 weeks. Clinical, pharmacological, and psychological data were recorded. A total 66 patients, 30 (median age: 34.0 [30.25-29.75] yoa) with acne and 36 patients (median age: 48 [43-54] years) with rosacea, were enrolled in this study. After 6 weeks of mask and quarantine, patients with acne displayed an increased Global Acne Grading Scale (GAGS) score in mask-related areas (P < .0001). Likewise, after 6 weeks of mask and quarantine, patients with rosacea displayed a worsen in both physican (P < .0001) and patient (P < .0001) reported outcomes. Remarkably, patients reported also a statistically significant decrease in their quality of life (P < .0001).Masks appear to trigger both acne and rosacea flares. Additional studies are needed to generate evidence and inform clinical decision-making.acne due to masks, COVID-19, mask rosacea, maskne, pandemics, rosacea due to masks | INTRODUCTIONDuring COVID-19 pandemics, the introduction of personal protective equipments (PPE), such as masks and gloves, drastically changed facial and hand dermatoses dermatoepidemiology. 1,2 Focusing on facial dermatoses, Hua et al 3 evaluated the short-term cutaneous impact of Giovanni Damiani and Laura C. Gironi have contributed equally to this study.

“…Despite the serious increase in the number of COVID‐19 cases especially in September, there was no decrease in the number of outpatient clinic visits. In a tertiary hospital from Turkey, the number of patients admitted to the dermatology clinic was 738 in April, and 1016 in May 10 . In our study, the number of patients increased every month, and 3004 patients were admitted in September.…”

Section: Discussionmentioning

confidence: 44%

Dermatology outpatient clinic outcomes after COVID ‐19 outbreak: What is new normal?

Çaytemel

Erdem

Agirgol

et al. 2021

Coronavirus disease‐2019 (COVID‐19), which emerged in late 2019 and caused a pandemic, has significantly affected outpatient admissions to dermatology outpatient clinics. There have been changes in the number and composition of the patients who applied to the outpatient clinics. The dermatology outpatient clinic applications have dramatically decreased due to restrictions and prohibitions, and active participation of dermatologists in the field immediately after the pandemic. The composition of the diagnoses has also altered for reasons such as excessive use of hygiene products and types of protective equipment usage related to COVID‐19. Intensive precautions have been taken in the first 3 months of the pandemic (March, April, and May). As of 12 May, controlled socialization started with new regulations. This period has been called “the normalization process.” This study aims to evaluate the changes of the patients admitted to dermatology outpatient clinics within the normalization process. Despite the increasing number of COVID‐19 patients and related deaths in the whole country with the new normal, the admissions to dermatology outpatient clinics have increased. During this period, acne and related diseases, pigmentation disorders, and viral skin infections had increased; dermatoses, xerosis cutis, and superficial fungal infections had reduced. It seems that nonurgent dermatological complaints affect the quality of life of patients and cause the need for an application. Although restrictions reduce these numbers, measures should be taken to protect patients and society during the ongoing pandemic.